Randolph Sophia 4
4 · ALX ONCOLOGY HOLDINGS INC · Filed Jun 13, 2023
Insider Transaction Report
Form 4
Randolph Sophia
Chief Medical Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2023-06-09−2,546→ 92,629 totalExercise: $4.08Exp: 2030-03-09→ Common Stock (2,546 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2023-06-09−6,256→ 19,084 totalExercise: $4.81Exp: 2030-04-27→ Common Stock (6,256 underlying) - Exercise/Conversion
Common Stock
2023-06-09$1.91/sh+4,027$7,692→ 274,280 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-06-09−4,027→ 0 totalExercise: $1.91Exp: 2029-09-12→ Common Stock (4,027 underlying) - Exercise/Conversion
Common Stock
2023-06-09$4.08/sh+2,546$10,388→ 276,826 total - Exercise/Conversion
Common Stock
2023-06-09$4.81/sh+6,256$30,091→ 283,082 total
Footnotes (3)
- [F1]The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019.
- [F2]The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.
- [F3]Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020.